Hydroxamic acid hybrids as histone deacetylase inhibitors for cancer therapy: an update (2022 to date)
Yanjing Cheng, Yafei Zhuang, Ni Zhu, Yu You, Meichun Hu
Topics & Concepts
ChemistryHistone deacetylaseHydroxamic acidVorinostatHistone deacetylase inhibitorCancer therapyAcetylationHistoneCancerCancer researchComputational biologyBiochemistryStereochemistryGeneticsDNAGeneBiologyHistone Deacetylase Inhibitors ResearchCatalytic C–H Functionalization MethodsSulfur-Based Synthesis Techniques